Article

Carolyn Presley Discusses the Burden of Curative Lung Cancer Treatment

Author(s):

Carolyn Presley

Carolyn Presley, clinical fellow, geriatric oncology, Yale Cancer Center, Robert Wood Johnson Clinical Scholar, discusses a study looking at the burden of health care on patients undergoing curative lung cancer care.

Carolyn Presley, clinical fellow, geriatric oncology, Yale Cancer Center, Robert Wood Johnson Clinical Scholar, discusses a study looking at the burden of health care on patients undergoing curative lung cancer care.

Read more about the study.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Minimally Invasive Surgery Transforms Lung Cancer Recovery
Image of man with text.
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Image of Staci.
Related Content
Image of FDA approval.
August 2nd 2025

Breaking Down Every FDA Approval Across Oncology During July 2025

Ryan Scott
Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic approaches across a range of disease types.
CURE Cancer Horizons logo
August 2nd 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of lungs.
August 2nd 2025

July Lung Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and patient-centered perspectives.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
August 2nd 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of woman.
August 2nd 2025

Facing Lung Cancer with Grace and Self-Compassion

Ryan Scott
Self-compassion, emotional openness, and community support is incredibly important for patients currently beginning their cancer journey.
Image of clinical trial.
August 2nd 2025

New Trials Advance Treatments for Lymphoma, Lung Cancer and Sarcomas

Spencer Feldman
New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK-positive lung cancer.